Medicines Safety Update provides practical information and advice on drug safety and information about emerging safety issues. It replaced the Australian Adverse Drug Reactions Bulletin in 2010. Domperidone is a gastrointestinal motility modifier indicated for the short-term treatment of symptoms associated with idiopathic or diabetic gastroparesis in adults, and is also indicated for intractable nausea and vomiting from any cause. The safety alert urges anyone taking domperidone not to stop taking the drug or change the dose before consulting with their doctors, and to ask their health-care providers if they have been given. In line with this recommendation, sections 4.3, 4.4 and 4.5 of the SmPC for all domperidone containing products should be updated to reflect, that domperidone, as an ex ception, may be co-administered Domperidone is a dopamine antagonist with antiemetic properties. A European review assessed the benefits and risks of domperidone following continued reports of cardiac side effects. The review. Domperidone is a dopamine antagonist with antiemetic properties. It should no longer be sold to anyone without a prescription. It is associated with a small increased risk of serious cardiac side. Drug Safety. 33(11): 1003-14. Johannes CB, Varas-Lorenzo C, McQuay LJ, et al. 2010. Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study. A European medicines regulatory body (CMDh) has endorsed recommendations from the European Medicines Agency (EMA) to restrict the use of medications containing domperidone. Domperidone containing products have authorised nationally been in several EU member states since the 1970s and have been available in the United Kingdom under the trade name Motilium and as the generic, domperidone. List of Union reference dates and frequency of submission of periodic safety update reports (PSURs) Related Information: Introductory cover note to the List of European Union reference dates and frequency of submission of PSURs including requirements for PSURs submission.
Latest News
- valor de la depo provera
- tylenol advil for dogs
- maxalt for migraine user reviews
- cytotec 400 mg
- shokugeki no soma raw 118
- dosis tamiflu para niños
- can i take soma with valium
- synthroid and lack of appetite
- porque los hombres no reglan
- package insert for cytoxan
- tratamiento con finasteride 1mg
- hair regrowth after taxotere cytoxan
- clobetasol hair thinning
- duphaston en acne
- how old should you be to take accutane
- benicar celiac lawsuit
- comparative beneficial effects of simvastatin and pravastatin
- is amoxicillin safe to take when you are pregnant
- augmentin bid 200 28 yan etkileri
- renova me senhor jesus aline barros krafta
- dual antiplatelet and warfarin
- tretinoin scars worse
- can stopping prozac cause weight loss
- tapering off of effexor xr